CONRAD RIOS: Open Payments
NPI 1326037771 · CHOWCHILLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,101 in 38 payments from 19 companies in 2025. Trend: 2023 $1,746 · 2024 $2,228 · 2025 $4,101
Food & beverage: $4,101
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $743 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $416 |
| Novo Nordisk Inc | 3 | $375 |
| Amgen Inc. | 4 | $344 |
| Phathom Pharmaceuticals, Inc. | 2 | $250 |
| Ardelyx, Inc. | 2 | $246 |
| Axsome Therapeutics, Inc. | 2 | $224 |
| Corcept Therapeutics | 2 | $212 |
| Alnylam Pharmaceuticals Inc. | 1 | $150 |
| Madrigal Pharmaceuticals | 1 | $146 |
Products named: AIRSUPRA, BREZTRI, VOQUEZNA, Ozempic, IBSRELA, Auvelity, Repatha, Korlym.
Industry payments across CA — which companies pay providers there.
